{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:09:03Z","timestamp":1768453743800,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009726","name":"Foundation for Angelman Syndrome Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009726","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Neuroscience"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.mcn.2022.103724","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:29:13Z","timestamp":1648762153000},"page":"103724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Recovery of Angelman syndrome rat deficits with UBE3A protein supplementation"],"prefix":"10.1016","volume":"120","author":[{"given":"Andie","family":"Dodge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole K.","family":"Morrill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin J.","family":"Weeber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin R.","family":"Nash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcn.2022.103724_bb0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41398-020-0720-2","article-title":"Translational outcomes in a full gene deletion of ubiquitin protein ligase E3A rat model of Angelman syndrome","volume":"10","author":"Berg","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.mcn.2022.103724_bb0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/TACG.S57386","article-title":"Angelman syndrome: review of clinical and molecular aspects","volume":"7","author":"Bird","year":"2014","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.mcn.2022.103724_bb0015","doi-asserted-by":"crossref","first-page":"8451","DOI":"10.1038\/s41598-017-08825-x","article-title":"Strain-dependence of the angelman syndrome phenotypes in Ube3a maternal deficiency mice","volume":"7","author":"Born","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.mcn.2022.103724_bb0020","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0345-20.2020","article-title":"Early developmental EEG and seizure phenotypes in a full gene deletion of ubiquitin protein ligase E3A rat model of Angelman syndrome","volume":"8","author":"Born","year":"2021","journal-title":"eNeuro"},{"key":"10.1016\/j.mcn.2022.103724_bb0025","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/cne.24063","article-title":"Subcellular organization of UBE3A in neurons","volume":"525","author":"Burette","year":"2017","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.mcn.2022.103724_bb0030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13229-018-0238-0","article-title":"Subcellular organization of UBE3A in human cerebral cortex","volume":"9","author":"Burette","year":"2018","journal-title":"Mol. Autism."},{"key":"10.1016\/j.mcn.2022.103724_bb0035","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jneumeth.2010.10.010","article-title":"Convection-enhanced delivery and systemic mannitol increase gene product distribution of AAV vectors 5, 8, and 9 and increase gene product in the adult mouse brain","volume":"194","author":"Carty","year":"2010","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.mcn.2022.103724_bb0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2010.03.011","article-title":"Neurodevelopmental disorders involving genomic imprinting at human chromosome 15q11-q13","volume":"39","author":"Chamberlain","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mcn.2022.103724_bb0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nbd.2016.08.002","article-title":"Ketone ester supplementation attenuates seizure activity, and improves behavior and hippocampal synaptic plasticity in an angelman syndrome mouse model","volume":"96","author":"Ciarlone","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mcn.2022.103724_bb0050","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neuropharm.2016.12.009","article-title":"Effects of the synthetic neurosteroid ganaxolone on seizure activity and behavioral deficits in an angelman syndrome mouse model","volume":"116","author":"Ciarlone","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mcn.2022.103724_bb0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/jmg.40.2.87","article-title":"Angelman syndrome: a review of the clinical and genetic aspects","volume":"40","author":"Clayton-Smith","year":"2003","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.mcn.2022.103724_bb0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/ajmg.a.61385","article-title":"Behavioral characterization of dup15q syndrome: toward meaningful endpoints for clinical trials","volume":"182","author":"DiStefano","year":"2020","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.mcn.2022.103724_bb0065","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/aur.2267","article-title":"Generation of a novel rat model of angelman syndrome with a complete Ube3a gene deletion","volume":"13","author":"Dodge","year":"2020","journal-title":"Autism Res."},{"issue":"4","key":"10.1016\/j.mcn.2022.103724_bb0070","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/aur.2475","article-title":"Identification of UBE3A protein in CSF and extracellular space of the hippocampus suggest a potential novel function in synaptic plasticity","volume":"14","author":"Dodge","year":"2021","journal-title":"Autism Res."},{"key":"10.1016\/j.mcn.2022.103724_bb0075","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004655","article-title":"Decreased tonic inhibition in cerebellar granule cells causes motor dysfunction in a mouse model of Angelman syndrome","volume":"4","author":"Egawa","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.mcn.2022.103724_bb0080","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.1007\/s12035-018-0871-9","article-title":"Loss of angelman syndrome protein E6AP disrupts a novel antagonistic estrogen-retinoic acid transcriptional crosstalk in neurons","volume":"55","author":"El Hokayem","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.mcn.2022.103724_bb0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbr.2012.12.052","article-title":"Behavioral deficits in an angelman syndrome model: effects of genetic background and age","volume":"243","author":"Huang","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.mcn.2022.103724_bb0090","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0896-6273(00)80596-6","article-title":"Mutation of the angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation","volume":"21","author":"Jiang","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.mcn.2022.103724_bb0095","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuron.2016.02.040","article-title":"GABAergic neuron-specific loss of Ube3a causes angelman syndrome-like EEG abnormalities and enhances seizure susceptibility","volume":"90","author":"Judson","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.mcn.2022.103724_bb0100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fnmol.2019.00109","article-title":"The autism and angelman syndrome protein Ube3A\/E6AP: the gene, E3 ligase ubiquitination targets and neurobiological functions","volume":"12","author":"Khatri","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.mcn.2022.103724_bb0105","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2217\/epi.15.70","article-title":"Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders","volume":"7","author":"LaSalle","year":"2015","journal-title":"Epigenomics"},{"key":"10.1016\/j.mcn.2022.103724_bb0110","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1080\/15592294.2017.1376151","article-title":"UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons","volume":"12","author":"Lopez","year":"2017","journal-title":"Epigenetics"},{"key":"10.1016\/j.mcn.2022.103724_bb0115","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fnmol.2018.00476","article-title":"UBE3A: an E3 ubiquitin ligase with genome-wide impact in neurodevelopmental disease","volume":"11","author":"Lopez","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.mcn.2022.103724_bb0120","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1111\/febs.15258","article-title":"Angelman syndrome: a journey through the brain","volume":"287","author":"Maranga","year":"2020","journal-title":"FEBS J."},{"key":"10.1016\/j.mcn.2022.103724_bb0125","article-title":"Adenosine A2A receptors format long-term depression and memory strategies in a mouse model of angelman syndrome","volume":"105137","author":"Moreira-de-Sa","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mcn.2022.103724_bb0130","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1523\/JNEUROSCI.1846-13.2014","article-title":"Changes in mGlu5 receptor-dependent synaptic plasticity and coupling to homer proteins in the hippocampus of Ube3A hemizygous mice modeling angelman syndrome","volume":"34","author":"Pignatelli","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2022.103724_bb0135","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.1523\/JNEUROSCI.0083-18.2018","article-title":"Adult Ube3a gene reinstatement restores the electrophysiological deficits of prefrontal cortex layer 5 neurons in a mouse model of angelman syndrome","volume":"38","author":"Rotaru","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2022.103724_bb0140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1196\/annals.1417.020","article-title":"Fear conditioning and long-term potentiation in the amygdala: what really is the connection?","volume":"1129","author":"Sah","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"18","key":"10.1016\/j.mcn.2022.103724_bb0145","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/hmg\/ddaa191","article-title":"Abundance and localization of human UBE3A protein isoforms","volume":"29","author":"Sirois","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mcn.2022.103724_bb0150","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.bbadis.2008.06.005","article-title":"Extracellular, circulating proteasomes and ubiquitin - incidence and relevance","volume":"1782","author":"Sixt","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mcn.2022.103724_bb0155","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002627","article-title":"Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice","volume":"3","author":"Smith","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.mcn.2022.103724_bb0160","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4190390","article-title":"Advantages of extracellular ubiquitin in modulation of immune responses","volume":"2016","author":"Sujashvili","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.mcn.2022.103724_bb0165","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.celrep.2015.06.023","article-title":"UBE3A regulates synaptic plasticity and learning and memory by controlling SK2 channel endocytosis","volume":"12","author":"Sun","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.mcn.2022.103724_bb0170","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pediatrneurol.2012.09.015","article-title":"Neurologic manifestations of angelman syndrome","volume":"48","author":"Thibert","year":"2013","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.mcn.2022.103724_bb0175","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1523\/JNEUROSCI.23-07-02634.2003","article-title":"Derangements of hippocampal calcium\/calmodulin-dependent protein kinase II in a mouse model for angelman mental retardation syndrome","volume":"23","author":"Weeber","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2022.103724_bb0180","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ajmg.a.31074","article-title":"Angelman syndrome 2005: updated consensus for diagnostic criteria","volume":"140","author":"Williams","year":"2006","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.mcn.2022.103724_bb0185","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/GIM.0b013e3181def138","article-title":"Clinical and genetic aspects of Angelman syndrome","volume":"12","author":"Williams","year":"2010","journal-title":"Genet. Med."},{"key":"10.1016\/j.mcn.2022.103724_bb0190","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1093\/hmg\/ddaa194","article-title":"Conserved UBE3A subcellular distribution between human and mice is facilitated by non-homologous isoforms","volume":"29","author":"Zampeta","year":"2020","journal-title":"Hum. Mol. Genet."}],"container-title":["Molecular and Cellular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743122000306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743122000306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:13:13Z","timestamp":1760922793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044743122000306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":38,"alternative-id":["S1044743122000306"],"URL":"https:\/\/doi.org\/10.1016\/j.mcn.2022.103724","relation":{},"ISSN":["1044-7431"],"issn-type":[{"value":"1044-7431","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recovery of Angelman syndrome rat deficits with UBE3A protein supplementation","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcn.2022.103724","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103724"}}